Med Life (LTS:0RO5) Tax Expense: lei19 Mil (TTM As of Mar. 2026)


LTS:0RO5 Med Life SA LTS:0RO5
75 GF Score
Price lei11.38
GF Value lei1.39
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Med Life Tax Expense?

Med Life LTS:0RO5 75 Tax Expense is lei19 Mil as of Mar. 2026. GuruFocus rates LTS:0RO5 with a GF Score™ of 75/100 and a GF Value™ of lei1.39 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Med Life's tax expense for the months ended in Mar. 2026 was lei7 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was lei19 Mil.


Med Life  (LTS:0RO5) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Med Life Tax Expense Related Terms


Med Life Tax Expense Historical Data

* Premium members only.

The historical data trend for Med Life's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med Life Tax Expense Chart

Med Life Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.79 22.51 12.13 8.46 25.96

Med Life Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.91 7.01 4.78 7.39 7.18
LTS:0RO5
75GF Score
Med Life SA LTS:0RO5
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Life Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of lei19 Mil mean?
Med Life (LTS:0RO5) has a Tax Expense of lei19 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Med Life and its competitors.
Is Med Life's Tax Expense too high?
Med Life's current Tax Expense is lei19 Mil. Overall, Med Life has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Tax Expense compare to HCA and THC?
Med Life's Tax Expense of lei19 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Healthcare Providers & Services company?
A good Tax Expense depends on the Healthcare Providers & Services industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Med Life and its competitors. Med Life's current Tax Expense is lei19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.39, compared to a current price of lei11.38 — trading 718.4% above its estimated fair value. The current Tax Expense is lei19 Mil. Med Life's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current Tax Expense is lei19 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Med Life (LTS:0RO5) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei11.38 is trading 718.4% above its estimated GF Value™ of lei1.39. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for LTS:0RO5:

  • Tax Expense: lei19 Mil
  • GF Value™: lei1.39 vs. price of lei11.38 (718.4% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Med Life Business Description

Other Exchanges M:RomaniaO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
75GF Score

Get the complete analysis for LTS:0RO5

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei11.38
Price
lei1.39
GF Value